NO316841B1 - Anvendelse av protein og aldehyd for fremstilling av klebemiddel, samt utstyrssett og applikator - Google Patents
Anvendelse av protein og aldehyd for fremstilling av klebemiddel, samt utstyrssett og applikator Download PDFInfo
- Publication number
- NO316841B1 NO316841B1 NO19950044A NO950044A NO316841B1 NO 316841 B1 NO316841 B1 NO 316841B1 NO 19950044 A NO19950044 A NO 19950044A NO 950044 A NO950044 A NO 950044A NO 316841 B1 NO316841 B1 NO 316841B1
- Authority
- NO
- Norway
- Prior art keywords
- protein
- aldehyde
- adhesive
- use according
- weight
- Prior art date
Links
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 63
- 239000000853 adhesive Substances 0.000 title claims abstract description 61
- 102000004169 proteins and genes Human genes 0.000 title claims description 28
- 108090000623 proteins and genes Proteins 0.000 title claims description 28
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 title 1
- 239000000463 material Substances 0.000 claims abstract description 107
- 239000000203 mixture Substances 0.000 claims abstract description 34
- 150000001299 aldehydes Chemical class 0.000 claims description 41
- 235000018102 proteins Nutrition 0.000 claims description 27
- 102000004506 Blood Proteins Human genes 0.000 claims description 25
- 108010017384 Blood Proteins Proteins 0.000 claims description 25
- 235000004252 protein component Nutrition 0.000 claims description 17
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 16
- 208000031737 Tissue Adhesions Diseases 0.000 claims description 13
- 229920001744 Polyaldehyde Polymers 0.000 claims description 12
- 102000034238 globular proteins Human genes 0.000 claims description 12
- 108091005896 globular proteins Proteins 0.000 claims description 12
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- 102000009027 Albumins Human genes 0.000 claims description 8
- 108010088751 Albumins Proteins 0.000 claims description 8
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical group N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims description 6
- 229940015043 glyoxal Drugs 0.000 claims description 5
- 229920002994 synthetic fiber Polymers 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- PCSMJKASWLYICJ-UHFFFAOYSA-N Succinic aldehyde Chemical compound O=CCCC=O PCSMJKASWLYICJ-UHFFFAOYSA-N 0.000 claims description 2
- JGEMYUOFGVHXKV-UPHRSURJSA-N malealdehyde Chemical compound O=C\C=C/C=O JGEMYUOFGVHXKV-UPHRSURJSA-N 0.000 claims description 2
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 12
- 239000003106 tissue adhesive Substances 0.000 abstract description 7
- 239000000243 solution Substances 0.000 description 31
- 239000007787 solid Substances 0.000 description 26
- 210000001519 tissue Anatomy 0.000 description 21
- 238000002156 mixing Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 12
- 229940098773 bovine serum albumin Drugs 0.000 description 12
- 210000002381 plasma Anatomy 0.000 description 12
- -1 polyethylene Polymers 0.000 description 11
- 108010049003 Fibrinogen Proteins 0.000 description 7
- 102000008946 Fibrinogen Human genes 0.000 description 7
- 229940012952 fibrinogen Drugs 0.000 description 7
- 235000013372 meat Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 230000002792 vascular Effects 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 6
- 108010073385 Fibrin Proteins 0.000 description 5
- 102000009123 Fibrin Human genes 0.000 description 5
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 5
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 229950003499 fibrin Drugs 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 229920004934 Dacron® Polymers 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 108010058846 Ovalbumin Proteins 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- 108010058237 plasma protein fraction Proteins 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 229920001651 Cyanoacrylate Polymers 0.000 description 3
- 238000004026 adhesive bonding Methods 0.000 description 3
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 3
- 229960004279 formaldehyde Drugs 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 229940092253 ovalbumin Drugs 0.000 description 3
- 238000007248 oxidative elimination reaction Methods 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000012460 protein solution Substances 0.000 description 3
- 229920002379 silicone rubber Polymers 0.000 description 3
- 239000004945 silicone rubber Substances 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000019256 formaldehyde Nutrition 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- QRWOVIRDHQJFDB-UHFFFAOYSA-N isobutyl cyanoacrylate Chemical compound CC(C)COC(=O)C(=C)C#N QRWOVIRDHQJFDB-UHFFFAOYSA-N 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 108010071289 Factor XIII Proteins 0.000 description 1
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004830 Super Glue Substances 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 229940019700 blood coagulation factors Drugs 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229940012444 factor xiii Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006261 foam material Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000004023 fresh frozen plasma Substances 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000002649 leather substitute Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 229920009441 perflouroethylene propylene Polymers 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 229940002993 plasmanate Drugs 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920006124 polyolefin elastomer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 229940075469 tissue adhesives Drugs 0.000 description 1
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09H—PREPARATION OF GLUE OR GELATINE
- C09H11/00—Adhesives based on glue or gelatine
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J189/00—Adhesives based on proteins; Adhesives based on derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Materials For Medical Uses (AREA)
- Phenolic Resins Or Amino Resins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90847492A | 1992-07-06 | 1992-07-06 | |
| PCT/US1993/006375 WO1994001508A1 (en) | 1992-07-06 | 1993-07-06 | Aldehyde-cured proteinaceous adhesive |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO950044D0 NO950044D0 (no) | 1995-01-05 |
| NO950044L NO950044L (no) | 1995-03-03 |
| NO316841B1 true NO316841B1 (no) | 2004-06-01 |
Family
ID=25425857
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19950044A NO316841B1 (no) | 1992-07-06 | 1995-01-05 | Anvendelse av protein og aldehyd for fremstilling av klebemiddel, samt utstyrssett og applikator |
| NO20034965A NO20034965D0 (no) | 1992-07-06 | 2003-11-07 | Aldehydherdet, proteinholdig adhesiv |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20034965A NO20034965D0 (no) | 1992-07-06 | 2003-11-07 | Aldehydherdet, proteinholdig adhesiv |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5385606A (ko) |
| EP (1) | EP0650512B1 (ko) |
| JP (1) | JP3483882B2 (ko) |
| KR (1) | KR100305374B1 (ko) |
| CN (1) | CN1075952C (ko) |
| AT (1) | ATE207520T1 (ko) |
| AU (1) | AU4666193A (ko) |
| BR (1) | BR9306683A (ko) |
| CA (1) | CA2139590C (ko) |
| DE (1) | DE69331011T2 (ko) |
| DK (1) | DK0650512T3 (ko) |
| ES (1) | ES2161719T3 (ko) |
| FI (1) | FI114219B (ko) |
| HK (1) | HK1013094A1 (ko) |
| IL (1) | IL106248A (ko) |
| MX (1) | MX9304053A (ko) |
| NO (2) | NO316841B1 (ko) |
| PH (1) | PH31208A (ko) |
| PT (1) | PT650512E (ko) |
| TW (1) | TW369418B (ko) |
| WO (1) | WO1994001508A1 (ko) |
| ZA (1) | ZA934840B (ko) |
Families Citing this family (138)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5749968A (en) * | 1993-03-01 | 1998-05-12 | Focal, Inc. | Device for priming for improved adherence of gels to substrates |
| US5800373A (en) * | 1995-03-23 | 1998-09-01 | Focal, Inc. | Initiator priming for improved adherence of gels to substrates |
| USRE38827E1 (en) | 1994-07-27 | 2005-10-11 | 3M Innovative Properties Company | Adhesive sealant composition |
| US5583114A (en) * | 1994-07-27 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
| FR2726571B1 (fr) * | 1994-11-03 | 1997-08-08 | Izoret Georges | Colle biologique, procede de preparation et dispositif d'application pour colle biologique, et durcisseurs pour colle biologique |
| US5900245A (en) | 1996-03-22 | 1999-05-04 | Focal, Inc. | Compliant tissue sealants |
| ATE369402T1 (de) | 1995-03-23 | 2007-08-15 | Genzyme Corp | Redox und photoinitiatorsystem zur grundierung von verbesserter adhäsion von gelen zu substraten |
| US5817303A (en) * | 1995-05-05 | 1998-10-06 | Protein Polymer Technologies, Inc. | Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer |
| US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US6706690B2 (en) | 1999-06-10 | 2004-03-16 | Baxter Healthcare Corporation | Hemoactive compositions and methods for their manufacture and use |
| US7320962B2 (en) | 1996-08-27 | 2008-01-22 | Baxter International Inc. | Hemoactive compositions and methods for their manufacture and use |
| US8603511B2 (en) | 1996-08-27 | 2013-12-10 | Baxter International, Inc. | Fragmented polymeric compositions and methods for their use |
| US7871637B2 (en) | 1996-08-27 | 2011-01-18 | Baxter International Inc. | Dry hemostatic compositions and methods for their preparation |
| US8303981B2 (en) | 1996-08-27 | 2012-11-06 | Baxter International Inc. | Fragmented polymeric compositions and methods for their use |
| US7435425B2 (en) * | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
| ZA978537B (en) | 1996-09-23 | 1998-05-12 | Focal Inc | Polymerizable biodegradable polymers including carbonate or dioxanone linkages. |
| FR2754268B1 (fr) † | 1996-10-07 | 1998-12-24 | Dev Des Utilisations Du Collag | Composition adhesive a base de polyaldehyde macromoleculaire et procede de reticulation de collagene ou de gelatine |
| US6168788B1 (en) | 1997-09-26 | 2001-01-02 | Leon Wortham | Fibrin glue without fibrinogen and biosealant compositions and methods |
| EP1018944A4 (en) * | 1997-09-26 | 2001-08-22 | Cryolife Inc | SEAMLESS, BIOADHESIVALLY USING ANASTOMOSIS TECHNOLOGY AND DEVICE THEREFOR |
| US20020022588A1 (en) * | 1998-06-23 | 2002-02-21 | James Wilkie | Methods and compositions for sealing tissue leaks |
| US7662409B2 (en) * | 1998-09-25 | 2010-02-16 | Gel-Del Technologies, Inc. | Protein matrix materials, devices and methods of making and using thereof |
| US6526674B1 (en) * | 1998-12-09 | 2003-03-04 | Domnick Hunter Limited | Gas dryer |
| US6310036B1 (en) | 1999-01-09 | 2001-10-30 | Last Chance Tissue Adhesives Corporation | High strength, Bio-compatible tissue adhesive and methods for treating vigorously bleeding surfaces |
| WO2000043050A1 (en) * | 1999-01-22 | 2000-07-27 | St. Jude Medical, Inc. | Medical adhesives |
| US6695859B1 (en) * | 1999-04-05 | 2004-02-24 | Coalescent Surgical, Inc. | Apparatus and methods for anastomosis |
| JP2000288079A (ja) | 1999-04-07 | 2000-10-17 | Toyobo Co Ltd | 生体組織用接着剤 |
| US6312725B1 (en) | 1999-04-16 | 2001-11-06 | Cohesion Technologies, Inc. | Rapid gelling biocompatible polymer composition |
| KR100328733B1 (ko) * | 1999-05-04 | 2002-03-14 | 윤덕용 | 프로티노이드를 포함하는 젤라틴 생체접합제 및 그의 제조방법 |
| US6921412B1 (en) * | 1999-05-18 | 2005-07-26 | Cryolife, Inc. | Self-supporting, shaped, three-dimensional biopolymeric materials and methods |
| AU770316B2 (en) * | 1999-05-18 | 2004-02-19 | Cryolife, Inc. | Self-supporting, shaped, three-dimensional biopolymeric materials and methods |
| US6372229B1 (en) * | 1999-09-15 | 2002-04-16 | Cryolife, Inc. | Vascular coating composition |
| ATE494014T1 (de) * | 2000-10-24 | 2011-01-15 | Cryolife Inc | Bioprothetischer füller und methoden, insbesondere für die bildung von bandscheibenbioprothesen in situ |
| US20040018228A1 (en) * | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
| EP1416946B1 (en) * | 2000-11-07 | 2017-12-20 | CryoLife, Inc. | Expandable foam-like biomaterials and methods |
| US6468660B2 (en) | 2000-12-29 | 2002-10-22 | St. Jude Medical, Inc. | Biocompatible adhesives |
| US20020173770A1 (en) * | 2001-05-16 | 2002-11-21 | Flory Alan R. | Adhesive delivery system |
| DE10152407A1 (de) * | 2001-10-24 | 2003-05-08 | Aesculap Ag & Co Kg | Zusammensetzung aus mindestens zwei biokompatiblen chemisch vernetzbaren Komponenten |
| US6951573B1 (en) | 2001-12-22 | 2005-10-04 | Dilling Emery W | Prosthetic aortic valve |
| AU2003221976A1 (en) * | 2002-04-16 | 2003-11-03 | Tyco Healthcare Group Lp | Method and apparatus for anastomosis including an expandable anchor |
| CA2703164C (en) | 2002-04-16 | 2013-10-08 | Tyco Healthcare Group Lp | Surgical stapler and method |
| CA2483778A1 (en) * | 2002-04-29 | 2003-11-13 | Gel-Del Technologies, Inc. | Biomatrix structural containment and fixation systems and methods of use thereof |
| AU2003228979A1 (en) * | 2002-05-10 | 2003-11-11 | Tyco Healthcare Group, Lp | Surgical stapling apparatus having a wound closure material applicator assembly |
| US7745532B2 (en) * | 2002-08-02 | 2010-06-29 | Cambridge Polymer Group, Inc. | Systems and methods for controlling and forming polymer gels |
| US20040024452A1 (en) * | 2002-08-02 | 2004-02-05 | Kruse Steven D. | Valved prostheses with preformed tissue leaflets |
| US7485670B2 (en) * | 2002-08-02 | 2009-02-03 | Cambridge Polymer Group, Inc. | Systems and methods for controlling and forming polymer gels |
| EP3915529A1 (en) * | 2002-08-06 | 2021-12-01 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Biocompatible phase invertible proteinaceous compositions and methods for making and using the same |
| US10098981B2 (en) | 2002-08-06 | 2018-10-16 | Baxter International Inc. | Biocompatible phase invertable proteinaceous compositions and methods for making and using the same |
| US8349348B2 (en) * | 2002-08-06 | 2013-01-08 | Matrix Medical, Llc | Biocompatible phase invertible proteinaceous compositions and methods for making and using the same |
| US9101536B2 (en) * | 2002-08-06 | 2015-08-11 | Matrix Medical Llc | Biocompatible phase invertable proteinaceous compositions and methods for making and using the same |
| DE10236152A1 (de) * | 2002-08-07 | 2004-02-19 | Marker Deutschland Gmbh | Ski- und Skibindungs-Kombination |
| US7493154B2 (en) * | 2002-10-23 | 2009-02-17 | Medtronic, Inc. | Methods and apparatus for locating body vessels and occlusions in body vessels |
| US6960209B2 (en) * | 2002-10-23 | 2005-11-01 | Medtronic, Inc. | Electrosurgical methods and apparatus for making precise incisions in body vessels |
| WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| US8377082B2 (en) * | 2003-01-14 | 2013-02-19 | Medtronic, Inc. | Methods and apparatus for making precise incisions in body vessels |
| US8834864B2 (en) * | 2003-06-05 | 2014-09-16 | Baxter International Inc. | Methods for repairing and regenerating human dura mater |
| US8465537B2 (en) * | 2003-06-17 | 2013-06-18 | Gel-Del Technologies, Inc. | Encapsulated or coated stent systems |
| JP4709479B2 (ja) * | 2003-07-03 | 2011-06-22 | 博 西田 | 高分子ミセルを有効成分とする組織接着剤 |
| US7129210B2 (en) * | 2003-07-23 | 2006-10-31 | Covalent Medical, Inc. | Tissue adhesive sealant |
| US7927626B2 (en) | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
| US20050090899A1 (en) * | 2003-10-24 | 2005-04-28 | Dipoto Gene | Methods and apparatuses for treating the spine through an access device |
| US7655012B2 (en) | 2003-10-02 | 2010-02-02 | Zimmer Spine, Inc. | Methods and apparatuses for minimally invasive replacement of intervertebral discs |
| AU2011224102B2 (en) * | 2003-12-08 | 2013-08-01 | Gel-Del Technologies, Inc. | Mucoadhesive drug delivery devices and methods of making and using thereof |
| EP1691746B1 (en) * | 2003-12-08 | 2015-05-27 | Gel-Del Technologies, Inc. | Mucoadhesive drug delivery devices and methods of making and using thereof |
| US20050165427A1 (en) * | 2004-01-22 | 2005-07-28 | Jahns Scott E. | Vessel sealing devices |
| US20050251180A1 (en) * | 2004-04-12 | 2005-11-10 | Vanderbilt University | Intravascular vessel anastomosis device |
| KR101148445B1 (ko) | 2004-04-28 | 2012-07-05 | 안지오디바이스 인터내셔널 게엠베하 | 가교된 생합성물질을 형성하기 위한 조성물 및 시스템, 및 이와 관련된 제조 및 사용 방법 |
| US20050281798A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Targeting sites of damaged lung tissue using composition |
| US20050281799A1 (en) | 2004-06-16 | 2005-12-22 | Glen Gong | Targeting damaged lung tissue using compositions |
| US20050281740A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Imaging damaged lung tissue |
| US20060004400A1 (en) * | 2004-06-16 | 2006-01-05 | Mcgurk Erin | Method of treating a lung |
| US20050281739A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Imaging damaged lung tissue using compositions |
| US7678767B2 (en) | 2004-06-16 | 2010-03-16 | Pneumrx, Inc. | Glue compositions for lung volume reduction |
| US7553810B2 (en) * | 2004-06-16 | 2009-06-30 | Pneumrx, Inc. | Lung volume reduction using glue composition |
| US7608579B2 (en) * | 2004-06-16 | 2009-10-27 | Pneumrx, Inc. | Lung volume reduction using glue compositions |
| JP5113519B2 (ja) * | 2004-07-08 | 2013-01-09 | ヌームアールエックス・インコーポレーテッド | 胸膜滲出の治療装置，治療方法及び材料 |
| WO2006005890A1 (fr) * | 2004-07-08 | 2006-01-19 | Symatese | Colle lyophilisee a base de collagene et son utilisation pour la fabrication de protheses collantes |
| FR2872822B1 (fr) * | 2004-07-08 | 2006-09-22 | Symatese Soc Par Actions Simpl | Colle lyophilisee a base de collagene et son utilisation pour la fabrication de protheses collantes |
| US7455682B2 (en) * | 2004-10-18 | 2008-11-25 | Tyco Healthcare Group Lp | Structure containing wound treatment material |
| US7825083B2 (en) | 2005-02-10 | 2010-11-02 | Spine Wave, Inc. | Synovial fluid barrier |
| US9248010B2 (en) * | 2005-07-15 | 2016-02-02 | Boston Scientific Scimed, Inc. | Tension-adjustable surgical sling assembly |
| US9402633B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
| US8157837B2 (en) * | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Minimally invasive lung volume reduction device and method |
| US8888800B2 (en) | 2006-03-13 | 2014-11-18 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
| US7934218B2 (en) * | 2006-03-30 | 2011-04-26 | International Business Machines Corporation | Interprocess communication management using a socket layer |
| CN101454030B (zh) * | 2006-05-31 | 2013-06-26 | 巴克斯特国际公司 | 用于脊柱外科手术中定向细胞向内生长和控制组织再生的方法 |
| DE102006033167A1 (de) | 2006-07-10 | 2008-01-24 | Gelita Ag | Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers |
| DE102006033168A1 (de) | 2006-07-10 | 2008-01-17 | Gelita Ag | Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung |
| CA2659612A1 (fr) | 2006-08-02 | 2008-02-07 | Khorionyx | Preparation implantable, utilisable notamment pour le complement tissulaire et la cicatrisation |
| TWI436793B (zh) * | 2006-08-02 | 2014-05-11 | Baxter Int | 快速作用之乾密封膠及其使用和製造方法 |
| EP2061486A4 (en) * | 2006-09-13 | 2011-11-16 | Southeastern Medical Technologies Llc | METHODS AND COMPOSITIONS FOR REFERRING AND ADHERING BIOLOGICAL TISSUES AND USES THEREOF |
| US20100297218A1 (en) * | 2006-09-20 | 2010-11-25 | Pneumrx, Inc. | Tissue adhesive compositions and methods thereof |
| US8911750B2 (en) * | 2007-04-03 | 2014-12-16 | Larry W. Tsai | Lung volume reduction therapy using crosslinked biopolymers |
| US20090011043A1 (en) * | 2007-07-03 | 2009-01-08 | Hua Xie | Tissue sealant made from whole blood |
| EP2214734B1 (en) | 2007-10-30 | 2017-12-13 | Baxter International Inc. | Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects |
| PL2219555T3 (pl) | 2007-12-03 | 2015-12-31 | Tenaxis Medical Inc | Biokompatybilne kompozycje białkowe ulegające przemianie fazowej |
| EP2237770A4 (en) * | 2007-12-26 | 2011-11-09 | Gel Del Technologies Inc | BIOCOMPATIBLE PROTEIN PARTICLES, PARTICLE DEVICES AND METHODS THEREOF |
| EP2259803B2 (en) | 2008-02-29 | 2019-03-13 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
| US9173669B2 (en) * | 2008-09-12 | 2015-11-03 | Pneumrx, Inc. | Enhanced efficacy lung volume reduction devices, methods, and systems |
| US20100256671A1 (en) * | 2009-04-07 | 2010-10-07 | Biomedica Management Corporation | Tissue sealant for use in noncompressible hemorrhage |
| US9155815B2 (en) | 2009-04-17 | 2015-10-13 | Tenaxis Medical, Inc. | Biocompatible phase invertible proteinaceous compositions and methods for making and using the same |
| US9039783B2 (en) * | 2009-05-18 | 2015-05-26 | Baxter International, Inc. | Method for the improvement of mesh implant biocompatibility |
| CN102573700B (zh) | 2009-05-18 | 2014-12-17 | 纽姆克斯股份有限公司 | 细长的肺减容装置在部署过程中的横截面变化 |
| PL2442835T3 (pl) * | 2009-06-16 | 2015-07-31 | Baxter Int | Gąbka hemostatyczna |
| WO2011079336A1 (en) | 2009-12-16 | 2011-07-07 | Baxter International Inc. | Hemostatic sponge |
| WO2011106437A1 (en) | 2010-02-23 | 2011-09-01 | Cryolife, Inc. | Applicator delivery tip extension |
| SA111320355B1 (ar) | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | إسفنجة لايقاف النزف |
| US8499764B2 (en) | 2010-05-26 | 2013-08-06 | The Invention Science Fund I, Llc | Portable apparatus for establishing an isolation field |
| CN103037845B (zh) | 2010-06-01 | 2015-11-25 | 巴克斯特国际公司 | 用于制备干燥、稳定的止血组合物的方法 |
| BR112012030457B1 (pt) | 2010-06-01 | 2021-03-09 | Baxter International Inc. | processo para fabricar uma composição hemostática seca e estável, recipiente acabado final, método para prover uma composição hemostática pronta para uso, e, kit para administrar uma composição hemostática |
| KR101814841B1 (ko) | 2010-06-01 | 2018-01-03 | 백스터 인터내셔널 인코포레이티드 | 건조 및 안정한 지혈 조성물의 제조 방법 |
| JP2012095769A (ja) * | 2010-10-29 | 2012-05-24 | Gunze Ltd | 医療用接着剤及び医療用材料 |
| US9044722B2 (en) | 2010-11-10 | 2015-06-02 | Darren Edward Nolen | Multi-component, temperature activated, tissue adhesive, sealing, and filling composition |
| US8911468B2 (en) | 2011-01-31 | 2014-12-16 | Vatrix Medical, Inc. | Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection |
| AU2012318257B2 (en) | 2011-10-11 | 2015-10-01 | Baxter Healthcare S.A. | Hemostatic compositions |
| US20130090291A1 (en) | 2011-10-11 | 2013-04-11 | Baxter Healthcare S.A. | Hemostatic compositions |
| UY34414A (es) | 2011-10-27 | 2013-04-30 | Baxter Int | Composiciones hemostáticas |
| KR101444877B1 (ko) | 2011-12-30 | 2014-10-01 | 주식회사 삼양바이오팜 | 감마폴리글루탐산으로 구성된 현장 가교 수화겔 및 그의 제조 방법 |
| RU2657955C2 (ru) | 2012-03-06 | 2018-06-18 | Ферросан Медикал Дивайсиз А/С | Контейнер под давлением, содержащий гемостатическую пасту |
| JP6394916B2 (ja) | 2012-06-12 | 2018-09-26 | フェロサン メディカル デバイシーズ エイ／エス | 乾燥止血組成物 |
| CN102977846B (zh) * | 2012-11-22 | 2015-06-24 | 北京林业大学 | 一种胶合板用胶粘剂及其制备方法 |
| CN102977847B (zh) * | 2012-11-22 | 2015-05-06 | 北京林业大学 | 一种胶合板用大豆蛋白胶粘剂及其制备方法 |
| CN103113847B (zh) * | 2013-01-31 | 2015-04-01 | 重庆知德文化传播有限公司 | 竹制品或木制品粘合剂的制备工艺 |
| US20140227665A1 (en) * | 2013-02-14 | 2014-08-14 | Dentsply International Inc. | Resorbable and curable compositions for use in dentistry |
| US9724078B2 (en) | 2013-06-21 | 2017-08-08 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
| WO2015061790A2 (en) | 2013-10-25 | 2015-04-30 | Pneumrx, Inc. | Genetically-associated chronic obstructive pulmonary disease treatment |
| CA2928963C (en) | 2013-12-11 | 2020-10-27 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
| US10390838B1 (en) | 2014-08-20 | 2019-08-27 | Pneumrx, Inc. | Tuned strength chronic obstructive pulmonary disease treatment |
| WO2016049625A1 (en) * | 2014-09-26 | 2016-03-31 | University Of South Carolina | Novel biofabrication techniques for the implementation of intrinsic tissue geometries to an in vitro collagen hydrogel |
| CA2960309A1 (en) | 2014-10-13 | 2016-04-21 | Ferrosan Medical Devices A/S | Dry composition for use in haemostasis and wound healing |
| JP6747650B2 (ja) | 2014-12-24 | 2020-08-26 | フェロサン メディカル デバイシーズ エイ／エス | 第１の物質と第２の物質を保持し混合するためのシリンジ |
| BR112017027695A2 (pt) | 2015-07-03 | 2018-09-04 | Ferrosan Medical Devices As | seringa para retenção e mistura de primeira e segunda substâncias |
| US10357362B2 (en) | 2015-12-09 | 2019-07-23 | Medtronic Vascular, Inc. | Valve delivery device with a piezochromatic feedback indicator and methods of use |
| CN112368028A (zh) | 2018-05-09 | 2021-02-12 | 弗罗桑医疗设备公司 | 用于制备止血组合物的方法 |
| WO2019231763A1 (en) | 2018-05-27 | 2019-12-05 | Christos Angeletakis | Tissue adhesives and sealants using naturally derived aldehydes |
| CN114430771A (zh) * | 2019-09-30 | 2022-05-03 | 丝芭博株式会社 | 蛋白质粘合剂、接合体及其制备方法 |
| EP3912709B1 (de) | 2020-05-19 | 2024-02-14 | Heraeus Medical GmbH | Vorrichtung und verfahren zum mischen von flüssigkeiten |
| CN113440644B (zh) * | 2021-06-10 | 2023-01-17 | 广东省科学院健康医学研究所 | 一种弹性白蛋白胶粘剂及其制备方法 |
| CN113694249A (zh) * | 2021-10-13 | 2021-11-26 | 中国科学院长春应用化学研究所 | 一种双组分蛋白粘合剂及其制备方法和应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE251126C (ko) * | ||||
| US2241868A (en) * | 1937-09-10 | 1941-05-13 | Hall Lab Inc | Method of processing blood |
| US2492458A (en) * | 1944-12-08 | 1949-12-27 | Jr Edgar A Bering | Fibrin foam |
| US2597228A (en) * | 1949-01-06 | 1952-05-20 | Armour & Co | Method of treating proteins with saturated aliphatic polyamines and resulting product |
| US3395106A (en) * | 1965-09-27 | 1968-07-30 | Miles Lab | Paper-coating composition containing modified dialdehyde polysacharide-modified polysaccharidereaction product |
| SU741878A1 (ru) * | 1978-01-31 | 1980-06-25 | Киевский Научно-Исследовательский Институт Гематологии И Переливания Крови | Способ получени гемостатической губки |
| AT359652B (de) * | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
| JPS5690867A (en) * | 1979-12-26 | 1981-07-23 | Konishi Kk | Quick-curing adhesive composition |
| AT366916B (de) * | 1980-04-02 | 1982-05-25 | Immuno Ag | Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen |
| JPS57149229A (en) * | 1981-03-13 | 1982-09-14 | Green Cross Corp:The | Frozen fibrinogen preparation |
| ATE20824T1 (de) * | 1981-06-25 | 1986-08-15 | Serapharm Gmbh & Co Kg | Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung. |
| DE3175003D1 (en) * | 1981-06-25 | 1986-08-28 | Serapharm Gmbh & Co Kg | Enriched plasma derivative for promoting wound sealing and wound healing |
| DE3203775A1 (de) * | 1982-02-04 | 1983-08-11 | Behringwerke Ag, 3550 Marburg | Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung |
| EP0085944B1 (de) * | 1982-02-10 | 1986-04-09 | Henkel Kommanditgesellschaft auf Aktien | Chirurgische Bindemittelsysteme zum Verkleben von körpereigenem Hartgewebe gewünschtenfalls mit Kunststoff und/oder Metall |
| DE3230849A1 (de) * | 1982-08-19 | 1984-02-23 | Behringwerke Ag, 3550 Marburg | Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung |
| CA1196863A (en) * | 1983-06-08 | 1985-11-19 | Mattheus F.A. Goosen | Slow release injectable insulin composition |
| US4983392A (en) * | 1983-11-14 | 1991-01-08 | Bio-Mimetics, Inc. | Bioadhesive compositions and methods of treatment therewith |
| US4627879A (en) * | 1984-09-07 | 1986-12-09 | The Trustees Of Columbia University In The City Of New York | Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma |
| AT390001B (de) * | 1984-09-28 | 1990-03-12 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern |
| JPS61246107A (ja) * | 1985-04-22 | 1986-11-01 | Sankin Kogyo Kk | 人体硬組織用修復材 |
| US4740534A (en) * | 1985-08-30 | 1988-04-26 | Sanyo Chemical Industries, Ltd. | Surgical adhesive |
| US4813958A (en) * | 1986-10-14 | 1989-03-21 | Hancock Jaffe Laboratories | Crosslinked anisotropic mammalian diaphragm in surgical reconstruction |
| CH673117A5 (ko) * | 1986-12-10 | 1990-02-15 | Ajinomoto Kk | |
| JPS63182559A (ja) * | 1987-01-24 | 1988-07-27 | Kanzaki Paper Mfg Co Ltd | 酵素電極の製造方法 |
| US5002769A (en) * | 1987-03-13 | 1991-03-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions for the sustained-release of chlorhexidine |
| DE3734923C1 (de) * | 1987-10-15 | 1989-01-26 | Biotest Pharma Gmbh | Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt |
| CN1049456A (zh) * | 1989-08-12 | 1991-02-27 | 莱阳农学院 | 动纤手术胶的配制 |
-
1993
- 1993-03-22 US US08/034,184 patent/US5385606A/en not_active Expired - Lifetime
- 1993-07-06 DK DK93916993T patent/DK0650512T3/da active
- 1993-07-06 AT AT93916993T patent/ATE207520T1/de active
- 1993-07-06 KR KR1019950700017A patent/KR100305374B1/ko not_active IP Right Cessation
- 1993-07-06 MX MX9304053A patent/MX9304053A/es unknown
- 1993-07-06 PH PH46458A patent/PH31208A/en unknown
- 1993-07-06 DE DE69331011T patent/DE69331011T2/de not_active Expired - Lifetime
- 1993-07-06 AU AU46661/93A patent/AU4666193A/en not_active Abandoned
- 1993-07-06 ZA ZA934840A patent/ZA934840B/xx unknown
- 1993-07-06 WO PCT/US1993/006375 patent/WO1994001508A1/en active IP Right Grant
- 1993-07-06 PT PT93916993T patent/PT650512E/pt unknown
- 1993-07-06 CN CN93109889A patent/CN1075952C/zh not_active Expired - Lifetime
- 1993-07-06 JP JP50347194A patent/JP3483882B2/ja not_active Expired - Lifetime
- 1993-07-06 IL IL10624893A patent/IL106248A/xx not_active IP Right Cessation
- 1993-07-06 EP EP93916993A patent/EP0650512B1/en not_active Expired - Lifetime
- 1993-07-06 BR BR9306683A patent/BR9306683A/pt not_active IP Right Cessation
- 1993-07-06 CA CA002139590A patent/CA2139590C/en not_active Expired - Lifetime
- 1993-07-06 ES ES93916993T patent/ES2161719T3/es not_active Expired - Lifetime
- 1993-07-21 TW TW082105805A patent/TW369418B/zh not_active IP Right Cessation
-
1995
- 1995-01-03 FI FI950024A patent/FI114219B/fi not_active IP Right Cessation
- 1995-01-05 NO NO19950044A patent/NO316841B1/no not_active IP Right Cessation
-
1998
- 1998-12-21 HK HK98114208A patent/HK1013094A1/xx not_active IP Right Cessation
-
2003
- 2003-11-07 NO NO20034965A patent/NO20034965D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2139590C (en) | 2004-06-29 |
| US5385606A (en) | 1995-01-31 |
| EP0650512A4 (en) | 1996-03-06 |
| IL106248A0 (en) | 1993-11-15 |
| ES2161719T3 (es) | 2001-12-16 |
| FI950024A (fi) | 1995-02-17 |
| CA2139590A1 (en) | 1994-01-20 |
| MX9304053A (es) | 1994-04-29 |
| PT650512E (pt) | 2002-02-28 |
| NO950044D0 (no) | 1995-01-05 |
| BR9306683A (pt) | 1998-12-08 |
| CN1085451A (zh) | 1994-04-20 |
| JP3483882B2 (ja) | 2004-01-06 |
| EP0650512B1 (en) | 2001-10-24 |
| DE69331011T2 (de) | 2002-03-14 |
| TW369418B (en) | 1999-09-11 |
| IL106248A (en) | 2000-07-26 |
| DK0650512T3 (da) | 2001-12-03 |
| EP0650512A1 (en) | 1995-05-03 |
| KR950702606A (ko) | 1995-07-29 |
| PH31208A (en) | 1998-05-05 |
| DE69331011D1 (de) | 2001-11-29 |
| ZA934840B (en) | 1994-08-29 |
| WO1994001508A1 (en) | 1994-01-20 |
| NO20034965D0 (no) | 2003-11-07 |
| HK1013094A1 (en) | 1999-08-13 |
| KR100305374B1 (ko) | 2002-04-24 |
| JPH07509262A (ja) | 1995-10-12 |
| NO950044L (no) | 1995-03-03 |
| AU4666193A (en) | 1994-01-31 |
| NO20034965L (no) | 1995-03-03 |
| ATE207520T1 (de) | 2001-11-15 |
| FI950024A0 (fi) | 1995-01-03 |
| CN1075952C (zh) | 2001-12-12 |
| FI114219B (fi) | 2004-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO316841B1 (no) | Anvendelse av protein og aldehyd for fremstilling av klebemiddel, samt utstyrssett og applikator | |
| US6074663A (en) | Method of using cross-linked fibrin material | |
| JP3735677B2 (ja) | 酸化分解で変性させた非架橋コラーゲンをベースとする外科用接着性組成物 | |
| US6310036B1 (en) | High strength, Bio-compatible tissue adhesive and methods for treating vigorously bleeding surfaces | |
| US5464471A (en) | Fibrin monomer based tissue adhesive | |
| CA2425935C (en) | Expandable foam-like biomaterials and methods | |
| JP2010504410A (ja) | 組織接着剤組成物およびその方法 | |
| JP2002524110A (ja) | 血管密封材および創傷被覆材として用いるためのｉ型コラーゲンおよびｉｉｉ型コラーゲン止血性組成物 | |
| AU2004259027A1 (en) | Tissue adhesive sealant | |
| JPS6340546B2 (ko) | ||
| WO2000072852A1 (en) | Prevention of post surgical adhesions using a fibrin monomer sealant | |
| JP2001511431A (ja) | Ｉ型およびｉｉｉ型コラーゲン接着剤組成物 | |
| US20080295735A1 (en) | Collagen-Based Lyophilised Glue and the Use Thereof for Producing an Adhesive Prosthesis | |
| CN111991611B (zh) | 一种可粘附自修复止血海绵及其制备方法 | |
| KR100306616B1 (ko) | 디알데히드 또는 폴리알데히드 및 단백질로 구성된 접착제조성물을 포함하는 키트 | |
| KR100304409B1 (ko) | 디알데히드 또는 폴리알데히드 및 단백질로 구성된 접착제조성물을 도포하는 도포기 | |
| CA2358567A1 (en) | Tissue adhesive for treating vigorously bleeding surfaces | |
| EP0686401A2 (en) | Living-tissue adhesive and blood coagulant | |
| JPH05208042A (ja) | 接着剤 | |
| Jackson | Fibrin sealant as a hemostatic agent in vascular surgery | |
| JP2003275293A (ja) | イオン結合性生体組織接着剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |